Historical background and taxonomy
For a long time, rubella was considered a mild and safe childhood disease. The viral nature of this disease was finally proven only in 1938 by researchers G. Hiro and S. Tasaka.
A real breakthrough in understanding the danger of the infection occurred in 1942, when Australian ophthalmologist N. M. Gregg established a direct link between the disease in pregnant women and severe malformations in infants. It was he who described the classic triad of congenital rubella, which includes cataracts, deafness, and various heart defects. The pathogen itself was isolated in cell culture much later, in 1962 (accomplished simultaneously by two independent groups of scientists led by T. Weller and P. Parkman).
In modern taxonomy, the pathogen belongs to the Togaviridae family and forms its own genus Rubivirus. The etymology of the name goes back to the Latin word rubrum (red), which indicates the characteristic clinical sign — maculopapular rash and general reddening of the patient's skin.
Virion morphology and structure
The rubella pathogen has a spherical shape. Its dimensions are relatively small — the virion diameter ranges from 60 to 70 nm. Hereditary information is encoded as a single-stranded positive-sense RNA (+ssRNA) molecule. The core of the virus is a protein capsid with icosahedral symmetry, over which lies a lipoprotein envelope (supercapsid) with pronounced surface spikes.
The virus structure includes three key structural proteins:
- Protein C (Capsid): forms the inner nucleocapsid.
- Glycoprotein E1: embedded in the supercapsid, responsible for the attachment (adsorption) of the virion to the membrane of a susceptible target cell. In the envelope, it forms a stable dimer with another glycoprotein.
- Glycoprotein E2: also located on the surface of the lipoprotein envelope (as part of spikes). This is the main protective antigen, which contains crucial strain-specific and virus-neutralizing epitopes.
Antigenic properties and resistance
The rubella virus is antigenically very stable — in nature, it exists as a single serotype. The internal nucleocapsid antigen (protein C) is traditionally detected using the complement fixation test (CFT). External surface glycoproteins not only ensure adsorption on human cells, but also impart hemagglutinating activity to the virus: it is able to agglutinate erythrocytes of certain birds, particularly pigeons, geese, and newborn (1–3-day-old) chicks.
In the external environment, the pathogen has low stability. The presence of a lipid envelope makes it extremely vulnerable to lipid solvents (ether, organic solvents, detergents). It is rapidly destroyed by formalin, chlorine-active compounds, as well as ultraviolet radiation and direct sunlight. The virus is thermolabile: when heated to 100 °C, it is completely inactivated in just 2 minutes. However, at low temperatures (in a frozen state), its infectious activity can persist for several years.
Cultivation features
In vitro propagation of the virus presents certain difficulties. In most cell cultures, it replicates actively, but does not cause a cytopathic effect (CPE), which seriously complicates its isolation and visualization.
The interference phenomenon is used for its detection. In primary cultures, rubella virus-infected cells become resistant to superinfection by other inducing viruses (e.g., ECHO-11 virus or vesicular stomatitis virus, which normally always cause CPE). If the monolayer remains intact after adding the inducer, this proves that the cell is already occupied by the rubella virus.
A direct cytopathic effect can only be observed in specific continuous cell lines (e.g., Vero, BHK-21) or in primary human fetal tissue cultures. In such cases, focal destruction of the monolayer, plaque formation under an agar overlay, and the appearance of cytoplasmic eosinophilic inclusions are noted.
Chicken and duck embryos, as well as monkeys, rats, and hamsters (in which the infection is asymptomatic) are used as biological models. Ferrets are of particular importance in virology: in these animals, the virus persistently infects parenchymal organs for a long time and is capable of transplacental transmission, making them an ideal model for studying the pathogenesis of human congenital rubella.
Briefly: answers to topical questions
What transmission routes are characteristic of the rubella virus?
Airborne droplet and transplacental routes of infection transmission are characteristic of the rubella virus.
- Airborne droplet route — is the main route upon contact with a sick person (with a clinically apparent or asymptomatic form), as well as upon contact with children with congenital rubella.
- Transplacental (vertical) route — transmission of the pathogen from an infected mother to the fetus, which leads to fetal damage and the development of congenital rubella.
What laboratory diagnostic methods are used to confirm rubella?
Virological, molecular biological, and serological laboratory diagnostic methods are used to confirm rubella.
- Serological method — the main complex (ELISA, IFA, HI, NT) aimed at detecting specific IgM and IgG class antibodies, as well as determining the IgG avidity index.
- Molecular biological method — PCR diagnostics to detect viral RNA in the test material (saliva, oropharyngeal swabs, blood, CSF).
- Virological method — isolation of the virus in cell cultures (rarely used due to complexity and labor intensity).
What is the mechanism of rubella virus penetration into a susceptible cell?
The rubella virus enters a susceptible cell via receptor-mediated endocytosis. The process begins with the attachment (adsorption) of the virion to the target cell, mediated by the surface glycoprotein E1 (external antigen forming spikes). Following entry into the cell via receptor endocytosis, viral uning (deproteinization) occurs. As a result of this process, the genomic positive-sense RNA is released into the cell cytoplasm for subsequent translation and replication.
Which vaccines are used for specific prevention of rubella?
Live attenuated vaccines are used for the specific prevention of rubella. Depending on the composition, the following types of preparations are used:
- Monovalent vaccines — rubella vaccines, for example, MERUVAX-2, RUDIVAX.
- Combination vaccines — include antigens against different infections. These include the mumps-rubella vaccine (MR-VAX-2) and the measles-mumps-rubella vaccine (MMR-2).
Routine vaccination is carried out according to the immunization schedule: at 12 months and 6 years of age; if the schedule is violated, girls are vaccinated at 13 years of age.
Gregg's triad (symptoms of congenital rubella) is easily remembered by the acronym CHD: Cataracts, Heart (defects), Deafness.
Class and exam questions
What family does the rubella virus belong to?
The causative agent belongs to the Togaviridae family, where it is classified into a separate genus, Rubivirus.
Which viral protein is the main protective antigen?
The main protective antigen is the surface glycoprotein E2, which contains virus-neutralizing and strain-specific epitopes.
Why is the interference phenomenon used when culturing the rubella virus?
Since the rubella virus does not cause a visible cytopathic effect (CPE) in most cell cultures, its presence is determined indirectly — by its ability to inhibit the replication of other viruses (e.g., ECHO-11).
Why is the infection dangerous for the fetus?
The virus has a pronounced teratogenic effect. When a mother is infected during pregnancy, it affects the fetus, causing the classic Gregg's triad: deafness, cataracts, and congenital heart defects.
What else to study on this topic
- Cellular and molecular mechanisms of the teratogenic action of the virus
- Features of pathogen persistence in parenchymal organs
- Specifics of the interaction of E1 and E2 glycoproteins with target cell receptors
- Transplacental transmission: a comparative analysis in ferret and human models
- Modern laboratory diagnostic methods for congenital rubella
Study the full topic in the «Microbiology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete guideline on the topic «Rubella virus» and 4,383 more pages on the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 141 video lectures on the subject
Other topics in the section "Togaviruses (alphaviruses, rubella)"
Entire section «Togaviruses (Alphaviruses, Rubella)»Free video lessons: microbiologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.